Company Name: Ablynx NV
Ablynx NV is a biopharmaceutical company. The company is engaged in the development of treatments for a variety of conditions in areas that include haematology, immuno-oncology, inflammation, oncology and respiratory disease using its proprietary Nanobody platform.
Ticker Symbol: ABLX (NASDAQ)
Company Website: http://www.ablynx.com
Headquarters: Ghent/Zwijnaarde, Belgium